Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zschiesche

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
British Journal of Clinical Pharmacology|October 1, 1991
N-acetylation and debrisoquine hydroxylation polymorphisms in patients with Gilbert's syndromeW Siegmund, J D Fengler, G Franke, et al.
Biochemical and Biophysical Research Communications|March 3, 1998
In vivo evidence for compromised phenylalanine metabolism in vitiligoK U Schallreuter, M Zschiesche, J Moore, et al.
Clinical Pharmacology and Therapeutics|August 17, 2000
Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoproteinK Westphal, A Weinbrenner, T Giessmann, et al.
Zeitschrift Fur Arztliche Fortbildung|January 1, 1988
[Prenatal biochemical diagnosis in genetically-induced metabolic diseases]G Machill, G Seidlitz, U Grimm, et al.
Neuromuscular Disorders : NMD|June 26, 1999
Severe clinical expression in X-linked Emery-Dreifuss muscular dystrophyM Hoeltzenbein, T Karow, J A Zeller, et al.
Journal of Inherited Metabolic Disease|September 10, 2005
A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrateO P van Diggelen, Ya V Voznyi, J L M Keulemans, et al.
Neuropediatrics|December 19, 2003
Niemann-Pick disease type A and B are clinically but also enzymatically heterogeneous: pitfall in the laboratory diagnosis of sphingomyelinase deficiency associated with the mutation Q292 KK Harzer, A Rolfs, P Bauer, et al.
Clinical Pharmacology and Therapeutics|November 4, 2000
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interactionK Westphal, A Weinbrenner, M Zschiesche, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
British Journal of Clinical Pharmacology|October 1, 1991
N-acetylation and debrisoquine hydroxylation polymorphisms in patients with Gilbert's syndromeW Siegmund, J D Fengler, G Franke, et al.
Biochemical and Biophysical Research Communications|March 3, 1998
In vivo evidence for compromised phenylalanine metabolism in vitiligoK U Schallreuter, M Zschiesche, J Moore, et al.
Clinical Pharmacology and Therapeutics|August 17, 2000
Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoproteinK Westphal, A Weinbrenner, T Giessmann, et al.
Zeitschrift Fur Arztliche Fortbildung|January 1, 1988
[Prenatal biochemical diagnosis in genetically-induced metabolic diseases]G Machill, G Seidlitz, U Grimm, et al.
Neuromuscular Disorders : NMD|June 26, 1999
Severe clinical expression in X-linked Emery-Dreifuss muscular dystrophyM Hoeltzenbein, T Karow, J A Zeller, et al.
Journal of Inherited Metabolic Disease|September 10, 2005
A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrateO P van Diggelen, Ya V Voznyi, J L M Keulemans, et al.
Neuropediatrics|December 19, 2003
Niemann-Pick disease type A and B are clinically but also enzymatically heterogeneous: pitfall in the laboratory diagnosis of sphingomyelinase deficiency associated with the mutation Q292 KK Harzer, A Rolfs, P Bauer, et al.
Clinical Pharmacology and Therapeutics|November 4, 2000
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interactionK Westphal, A Weinbrenner, M Zschiesche, et al.
Pageof 6